nodes	percent_of_prediction	percent_of_DWPC	metapath
Temozolomide—CYP3A4—Sibutramine—obesity	0.16	0.27	CbGbCtD
Temozolomide—CYP3A4—Benzphetamine—obesity	0.121	0.204	CbGbCtD
Temozolomide—CYP3A4—Bupropion—obesity	0.103	0.174	CbGbCtD
Temozolomide—CYP3A4—Orlistat—obesity	0.084	0.142	CbGbCtD
Temozolomide—CYP3A4—Cimetidine—obesity	0.0757	0.127	CbGbCtD
Temozolomide—CYP3A4—Topiramate—obesity	0.0495	0.0835	CbGbCtD
Temozolomide—CYP3A4—Irinotecan Pathway—NPC1—obesity	0.00047	0.0822	CbGpPWpGaD
Temozolomide—CYP3A4—Felbamate Metabolism—CYP2E1—obesity	0.000457	0.08	CbGpPWpGaD
Temozolomide—Chills—Bupropion—obesity	0.000337	0.000839	CcSEcCtD
Temozolomide—Vertigo—Sibutramine—obesity	0.000336	0.000839	CcSEcCtD
Temozolomide—Convulsion—Orlistat—obesity	0.000335	0.000836	CcSEcCtD
Temozolomide—Leukopenia—Sibutramine—obesity	0.000335	0.000836	CcSEcCtD
Temozolomide—Face oedema—Topiramate—obesity	0.000333	0.000832	CcSEcCtD
Temozolomide—Alopecia—Bupropion—obesity	0.000331	0.000827	CcSEcCtD
Temozolomide—Palpitations—Sibutramine—obesity	0.000331	0.000826	CcSEcCtD
Temozolomide—Myalgia—Orlistat—obesity	0.000329	0.000822	CcSEcCtD
Temozolomide—Mental disorder—Bupropion—obesity	0.000329	0.00082	CcSEcCtD
Temozolomide—Anxiety—Orlistat—obesity	0.000328	0.000819	CcSEcCtD
Temozolomide—Mood swings—Topiramate—obesity	0.000327	0.000816	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000327	0.000816	CcSEcCtD
Temozolomide—Cough—Sibutramine—obesity	0.000327	0.000815	CcSEcCtD
Temozolomide—Malnutrition—Bupropion—obesity	0.000326	0.000814	CcSEcCtD
Temozolomide—CYP3A4—Irinotecan Pathway—CES1—obesity	0.000326	0.057	CbGpPWpGaD
Temozolomide—Discomfort—Orlistat—obesity	0.000325	0.000812	CcSEcCtD
Temozolomide—Ataxia—Topiramate—obesity	0.000325	0.00081	CcSEcCtD
Temozolomide—Convulsion—Sibutramine—obesity	0.000324	0.000809	CcSEcCtD
Temozolomide—Hypertension—Sibutramine—obesity	0.000323	0.000807	CcSEcCtD
Temozolomide—Dry mouth—Orlistat—obesity	0.000322	0.000804	CcSEcCtD
Temozolomide—Dehydration—Topiramate—obesity	0.000321	0.000801	CcSEcCtD
Temozolomide—Dysgeusia—Bupropion—obesity	0.00032	0.000798	CcSEcCtD
Temozolomide—Arthralgia—Sibutramine—obesity	0.000319	0.000795	CcSEcCtD
Temozolomide—Myalgia—Sibutramine—obesity	0.000319	0.000795	CcSEcCtD
Temozolomide—Anxiety—Sibutramine—obesity	0.000318	0.000793	CcSEcCtD
Temozolomide—Anaphylactic shock—Orlistat—obesity	0.000316	0.000788	CcSEcCtD
Temozolomide—Oedema—Orlistat—obesity	0.000316	0.000788	CcSEcCtD
Temozolomide—Back pain—Bupropion—obesity	0.000316	0.000788	CcSEcCtD
Temozolomide—Discomfort—Sibutramine—obesity	0.000315	0.000786	CcSEcCtD
Temozolomide—Hypokalaemia—Topiramate—obesity	0.000314	0.000784	CcSEcCtD
Temozolomide—Infection—Orlistat—obesity	0.000314	0.000783	CcSEcCtD
Temozolomide—Breast disorder—Topiramate—obesity	0.000312	0.000779	CcSEcCtD
Temozolomide—Dry mouth—Sibutramine—obesity	0.000312	0.000778	CcSEcCtD
Temozolomide—Toxic epidermal necrolysis—Topiramate—obesity	0.000311	0.000776	CcSEcCtD
Temozolomide—Aspartate aminotransferase increased—Topiramate—obesity	0.000311	0.000776	CcSEcCtD
Temozolomide—Nervous system disorder—Orlistat—obesity	0.00031	0.000773	CcSEcCtD
Temozolomide—Confusional state—Sibutramine—obesity	0.000308	0.000769	CcSEcCtD
Temozolomide—Vision blurred—Bupropion—obesity	0.000308	0.000768	CcSEcCtD
Temozolomide—Skin disorder—Orlistat—obesity	0.000307	0.000765	CcSEcCtD
Temozolomide—Tremor—Bupropion—obesity	0.000306	0.000763	CcSEcCtD
Temozolomide—Oedema—Sibutramine—obesity	0.000306	0.000762	CcSEcCtD
Temozolomide—Anaphylactic shock—Sibutramine—obesity	0.000306	0.000762	CcSEcCtD
Temozolomide—Hyperhidrosis—Orlistat—obesity	0.000305	0.000762	CcSEcCtD
Temozolomide—Alanine aminotransferase increased—Topiramate—obesity	0.000305	0.00076	CcSEcCtD
Temozolomide—Muscular weakness—Topiramate—obesity	0.000305	0.00076	CcSEcCtD
Temozolomide—Infection—Sibutramine—obesity	0.000304	0.000757	CcSEcCtD
Temozolomide—Ill-defined disorder—Bupropion—obesity	0.000303	0.000756	CcSEcCtD
Temozolomide—Anaemia—Bupropion—obesity	0.000302	0.000753	CcSEcCtD
Temozolomide—Abdominal distension—Topiramate—obesity	0.000301	0.00075	CcSEcCtD
Temozolomide—Agitation—Bupropion—obesity	0.0003	0.000748	CcSEcCtD
Temozolomide—Thrombocytopenia—Sibutramine—obesity	0.000299	0.000747	CcSEcCtD
Temozolomide—Dysphagia—Topiramate—obesity	0.000299	0.000745	CcSEcCtD
Temozolomide—Angioedema—Bupropion—obesity	0.000298	0.000744	CcSEcCtD
Temozolomide—Skin disorder—Sibutramine—obesity	0.000297	0.000741	CcSEcCtD
Temozolomide—Hyperhidrosis—Sibutramine—obesity	0.000295	0.000737	CcSEcCtD
Temozolomide—Malaise—Bupropion—obesity	0.000294	0.000734	CcSEcCtD
Temozolomide—Vertigo—Bupropion—obesity	0.000293	0.000732	CcSEcCtD
Temozolomide—Leukopenia—Bupropion—obesity	0.000292	0.000729	CcSEcCtD
Temozolomide—Anorexia—Sibutramine—obesity	0.000291	0.000727	CcSEcCtD
Temozolomide—Sweating increased—Topiramate—obesity	0.000291	0.000725	CcSEcCtD
Temozolomide—Palpitations—Bupropion—obesity	0.000289	0.00072	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Orlistat—obesity	0.000288	0.000718	CcSEcCtD
Temozolomide—Bronchitis—Topiramate—obesity	0.000287	0.000716	CcSEcCtD
Temozolomide—Insomnia—Orlistat—obesity	0.000286	0.000713	CcSEcCtD
Temozolomide—Cough—Bupropion—obesity	0.000285	0.000711	CcSEcCtD
Temozolomide—Paraesthesia—Orlistat—obesity	0.000284	0.000707	CcSEcCtD
Temozolomide—Pancytopenia—Topiramate—obesity	0.000283	0.000707	CcSEcCtD
Temozolomide—Convulsion—Bupropion—obesity	0.000283	0.000706	CcSEcCtD
Temozolomide—Hypertension—Bupropion—obesity	0.000282	0.000703	CcSEcCtD
Temozolomide—Dysuria—Topiramate—obesity	0.000279	0.000696	CcSEcCtD
Temozolomide—Neutropenia—Topiramate—obesity	0.000279	0.000696	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Sibutramine—obesity	0.000278	0.000695	CcSEcCtD
Temozolomide—Dyspepsia—Orlistat—obesity	0.000278	0.000694	CcSEcCtD
Temozolomide—Arthralgia—Bupropion—obesity	0.000278	0.000693	CcSEcCtD
Temozolomide—Myalgia—Bupropion—obesity	0.000278	0.000693	CcSEcCtD
Temozolomide—Upper respiratory tract infection—Topiramate—obesity	0.000277	0.000692	CcSEcCtD
Temozolomide—Anxiety—Bupropion—obesity	0.000277	0.000691	CcSEcCtD
Temozolomide—Insomnia—Sibutramine—obesity	0.000276	0.00069	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000276	0.000689	CcSEcCtD
Temozolomide—Pollakiuria—Topiramate—obesity	0.000276	0.000688	CcSEcCtD
Temozolomide—Erectile dysfunction—Topiramate—obesity	0.000275	0.000686	CcSEcCtD
Temozolomide—CYP3A4—Liver X Receptor Pathway—SCD—obesity	0.000275	0.0481	CbGpPWpGaD
Temozolomide—Discomfort—Bupropion—obesity	0.000275	0.000685	CcSEcCtD
Temozolomide—Decreased appetite—Orlistat—obesity	0.000275	0.000685	CcSEcCtD
Temozolomide—Paraesthesia—Sibutramine—obesity	0.000274	0.000685	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Orlistat—obesity	0.000273	0.00068	CcSEcCtD
Temozolomide—Dyspnoea—Sibutramine—obesity	0.000272	0.00068	CcSEcCtD
Temozolomide—Photosensitivity reaction—Topiramate—obesity	0.000272	0.00068	CcSEcCtD
Temozolomide—Fatigue—Orlistat—obesity	0.000272	0.000679	CcSEcCtD
Temozolomide—Dry mouth—Bupropion—obesity	0.000272	0.000678	CcSEcCtD
Temozolomide—Somnolence—Sibutramine—obesity	0.000272	0.000678	CcSEcCtD
Temozolomide—Weight increased—Topiramate—obesity	0.000272	0.000678	CcSEcCtD
Temozolomide—Weight decreased—Topiramate—obesity	0.00027	0.000674	CcSEcCtD
Temozolomide—Pain—Orlistat—obesity	0.00027	0.000674	CcSEcCtD
Temozolomide—Hyperglycaemia—Topiramate—obesity	0.000269	0.000672	CcSEcCtD
Temozolomide—Dyspepsia—Sibutramine—obesity	0.000269	0.000671	CcSEcCtD
Temozolomide—Confusional state—Bupropion—obesity	0.000269	0.00067	CcSEcCtD
Temozolomide—Pneumonia—Topiramate—obesity	0.000268	0.000668	CcSEcCtD
Temozolomide—Anaphylactic shock—Bupropion—obesity	0.000266	0.000665	CcSEcCtD
Temozolomide—Oedema—Bupropion—obesity	0.000266	0.000665	CcSEcCtD
Temozolomide—Infestation NOS—Topiramate—obesity	0.000266	0.000664	CcSEcCtD
Temozolomide—Infestation—Topiramate—obesity	0.000266	0.000664	CcSEcCtD
Temozolomide—Decreased appetite—Sibutramine—obesity	0.000266	0.000663	CcSEcCtD
Temozolomide—Depression—Topiramate—obesity	0.000265	0.000662	CcSEcCtD
Temozolomide—Infection—Bupropion—obesity	0.000265	0.00066	CcSEcCtD
Temozolomide—Stevens-Johnson syndrome—Topiramate—obesity	0.000264	0.000658	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Sibutramine—obesity	0.000264	0.000658	CcSEcCtD
Temozolomide—Pain—Sibutramine—obesity	0.000261	0.000652	CcSEcCtD
Temozolomide—Constipation—Sibutramine—obesity	0.000261	0.000652	CcSEcCtD
Temozolomide—Nervous system disorder—Bupropion—obesity	0.000261	0.000652	CcSEcCtD
Temozolomide—Neuropathy peripheral—Topiramate—obesity	0.000261	0.000651	CcSEcCtD
Temozolomide—Thrombocytopenia—Bupropion—obesity	0.000261	0.000651	CcSEcCtD
Temozolomide—Feeling abnormal—Orlistat—obesity	0.00026	0.000649	CcSEcCtD
Temozolomide—Stomatitis—Topiramate—obesity	0.000259	0.000647	CcSEcCtD
Temozolomide—Skin disorder—Bupropion—obesity	0.000259	0.000646	CcSEcCtD
Temozolomide—Urinary tract infection—Topiramate—obesity	0.000259	0.000645	CcSEcCtD
Temozolomide—Gastrointestinal pain—Orlistat—obesity	0.000258	0.000644	CcSEcCtD
Temozolomide—Hyperhidrosis—Bupropion—obesity	0.000258	0.000643	CcSEcCtD
Temozolomide—Anorexia—Bupropion—obesity	0.000254	0.000634	CcSEcCtD
Temozolomide—Feeling abnormal—Sibutramine—obesity	0.000252	0.000628	CcSEcCtD
Temozolomide—Urticaria—Orlistat—obesity	0.000251	0.000626	CcSEcCtD
Temozolomide—Gastrointestinal pain—Sibutramine—obesity	0.00025	0.000623	CcSEcCtD
Temozolomide—Sinusitis—Topiramate—obesity	0.00025	0.000623	CcSEcCtD
Temozolomide—Abdominal pain—Orlistat—obesity	0.00025	0.000623	CcSEcCtD
Temozolomide—Body temperature increased—Orlistat—obesity	0.00025	0.000623	CcSEcCtD
Temozolomide—Urticaria—Sibutramine—obesity	0.000243	0.000606	CcSEcCtD
Temozolomide—Musculoskeletal discomfort—Bupropion—obesity	0.000243	0.000606	CcSEcCtD
Temozolomide—Abdominal pain—Sibutramine—obesity	0.000242	0.000603	CcSEcCtD
Temozolomide—Body temperature increased—Sibutramine—obesity	0.000242	0.000603	CcSEcCtD
Temozolomide—Insomnia—Bupropion—obesity	0.000241	0.000601	CcSEcCtD
Temozolomide—Haemoglobin—Topiramate—obesity	0.00024	0.000599	CcSEcCtD
Temozolomide—Paraesthesia—Bupropion—obesity	0.000239	0.000597	CcSEcCtD
Temozolomide—Hepatitis—Topiramate—obesity	0.000239	0.000596	CcSEcCtD
Temozolomide—Haemorrhage—Topiramate—obesity	0.000239	0.000596	CcSEcCtD
Temozolomide—Hypoaesthesia—Topiramate—obesity	0.000238	0.000593	CcSEcCtD
Temozolomide—Hallucination—Topiramate—obesity	0.000238	0.000593	CcSEcCtD
Temozolomide—Dyspnoea—Bupropion—obesity	0.000238	0.000593	CcSEcCtD
Temozolomide—Pharyngitis—Topiramate—obesity	0.000237	0.000592	CcSEcCtD
Temozolomide—Somnolence—Bupropion—obesity	0.000237	0.000591	CcSEcCtD
Temozolomide—Urinary tract disorder—Topiramate—obesity	0.000236	0.000589	CcSEcCtD
Temozolomide—Oedema peripheral—Topiramate—obesity	0.000235	0.000587	CcSEcCtD
Temozolomide—Connective tissue disorder—Topiramate—obesity	0.000235	0.000586	CcSEcCtD
Temozolomide—Dyspepsia—Bupropion—obesity	0.000235	0.000585	CcSEcCtD
Temozolomide—Urethral disorder—Topiramate—obesity	0.000234	0.000584	CcSEcCtD
Temozolomide—Hypersensitivity—Orlistat—obesity	0.000233	0.00058	CcSEcCtD
Temozolomide—Decreased appetite—Bupropion—obesity	0.000232	0.000578	CcSEcCtD
Temozolomide—Visual impairment—Topiramate—obesity	0.00023	0.000574	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Bupropion—obesity	0.00023	0.000574	CcSEcCtD
Temozolomide—Fatigue—Bupropion—obesity	0.00023	0.000573	CcSEcCtD
Temozolomide—Constipation—Bupropion—obesity	0.000228	0.000568	CcSEcCtD
Temozolomide—Pain—Bupropion—obesity	0.000228	0.000568	CcSEcCtD
Temozolomide—Asthenia—Orlistat—obesity	0.000227	0.000565	CcSEcCtD
Temozolomide—Erythema multiforme—Topiramate—obesity	0.000226	0.000564	CcSEcCtD
Temozolomide—Hypersensitivity—Sibutramine—obesity	0.000225	0.000562	CcSEcCtD
Temozolomide—Pruritus—Orlistat—obesity	0.000223	0.000557	CcSEcCtD
Temozolomide—Eye disorder—Topiramate—obesity	0.000223	0.000557	CcSEcCtD
Temozolomide—Tinnitus—Topiramate—obesity	0.000223	0.000556	CcSEcCtD
Temozolomide—Flushing—Topiramate—obesity	0.000222	0.000553	CcSEcCtD
Temozolomide—Cardiac disorder—Topiramate—obesity	0.000222	0.000553	CcSEcCtD
Temozolomide—Feeling abnormal—Bupropion—obesity	0.00022	0.000548	CcSEcCtD
Temozolomide—Asthenia—Sibutramine—obesity	0.000219	0.000547	CcSEcCtD
Temozolomide—Gastrointestinal pain—Bupropion—obesity	0.000218	0.000544	CcSEcCtD
Temozolomide—Angiopathy—Topiramate—obesity	0.000217	0.000541	CcSEcCtD
Temozolomide—Pruritus—Sibutramine—obesity	0.000216	0.000539	CcSEcCtD
Temozolomide—Diarrhoea—Orlistat—obesity	0.000216	0.000539	CcSEcCtD
Temozolomide—Immune system disorder—Topiramate—obesity	0.000216	0.000538	CcSEcCtD
Temozolomide—Mediastinal disorder—Topiramate—obesity	0.000215	0.000537	CcSEcCtD
Temozolomide—Chills—Topiramate—obesity	0.000214	0.000535	CcSEcCtD
Temozolomide—Urticaria—Bupropion—obesity	0.000212	0.000528	CcSEcCtD
Temozolomide—Alopecia—Topiramate—obesity	0.000211	0.000527	CcSEcCtD
Temozolomide—Body temperature increased—Bupropion—obesity	0.000211	0.000525	CcSEcCtD
Temozolomide—Abdominal pain—Bupropion—obesity	0.000211	0.000525	CcSEcCtD
Temozolomide—Mental disorder—Topiramate—obesity	0.000209	0.000522	CcSEcCtD
Temozolomide—Diarrhoea—Sibutramine—obesity	0.000209	0.000522	CcSEcCtD
Temozolomide—Dizziness—Orlistat—obesity	0.000209	0.000521	CcSEcCtD
Temozolomide—Malnutrition—Topiramate—obesity	0.000208	0.000519	CcSEcCtD
Temozolomide—Erythema—Topiramate—obesity	0.000208	0.000519	CcSEcCtD
Temozolomide—Dysgeusia—Topiramate—obesity	0.000204	0.000508	CcSEcCtD
Temozolomide—Dizziness—Sibutramine—obesity	0.000202	0.000504	CcSEcCtD
Temozolomide—Back pain—Topiramate—obesity	0.000201	0.000502	CcSEcCtD
Temozolomide—Vomiting—Orlistat—obesity	0.000201	0.000501	CcSEcCtD
Temozolomide—Rash—Orlistat—obesity	0.000199	0.000497	CcSEcCtD
Temozolomide—Dermatitis—Orlistat—obesity	0.000199	0.000496	CcSEcCtD
Temozolomide—Headache—Orlistat—obesity	0.000198	0.000494	CcSEcCtD
Temozolomide—Hypersensitivity—Bupropion—obesity	0.000196	0.00049	CcSEcCtD
Temozolomide—Vision blurred—Topiramate—obesity	0.000196	0.000489	CcSEcCtD
Temozolomide—Tremor—Topiramate—obesity	0.000195	0.000486	CcSEcCtD
Temozolomide—Vomiting—Sibutramine—obesity	0.000194	0.000485	CcSEcCtD
Temozolomide—Ill-defined disorder—Topiramate—obesity	0.000193	0.000481	CcSEcCtD
Temozolomide—Rash—Sibutramine—obesity	0.000193	0.000481	CcSEcCtD
Temozolomide—Dermatitis—Sibutramine—obesity	0.000193	0.00048	CcSEcCtD
Temozolomide—Anaemia—Topiramate—obesity	0.000192	0.00048	CcSEcCtD
Temozolomide—Headache—Sibutramine—obesity	0.000191	0.000478	CcSEcCtD
Temozolomide—Asthenia—Bupropion—obesity	0.000191	0.000477	CcSEcCtD
Temozolomide—Agitation—Topiramate—obesity	0.000191	0.000477	CcSEcCtD
Temozolomide—Pruritus—Bupropion—obesity	0.000189	0.00047	CcSEcCtD
Temozolomide—Nausea—Orlistat—obesity	0.000188	0.000468	CcSEcCtD
Temozolomide—Malaise—Topiramate—obesity	0.000188	0.000468	CcSEcCtD
Temozolomide—Vertigo—Topiramate—obesity	0.000187	0.000466	CcSEcCtD
Temozolomide—Leukopenia—Topiramate—obesity	0.000186	0.000464	CcSEcCtD
Temozolomide—Palpitations—Topiramate—obesity	0.000184	0.000459	CcSEcCtD
Temozolomide—Diarrhoea—Bupropion—obesity	0.000182	0.000455	CcSEcCtD
Temozolomide—Nausea—Sibutramine—obesity	0.000182	0.000453	CcSEcCtD
Temozolomide—Cough—Topiramate—obesity	0.000182	0.000453	CcSEcCtD
Temozolomide—Convulsion—Topiramate—obesity	0.00018	0.00045	CcSEcCtD
Temozolomide—Hypertension—Topiramate—obesity	0.00018	0.000448	CcSEcCtD
Temozolomide—Myalgia—Topiramate—obesity	0.000177	0.000442	CcSEcCtD
Temozolomide—Arthralgia—Topiramate—obesity	0.000177	0.000442	CcSEcCtD
Temozolomide—Anxiety—Topiramate—obesity	0.000176	0.00044	CcSEcCtD
Temozolomide—Dizziness—Bupropion—obesity	0.000176	0.00044	CcSEcCtD
Temozolomide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000176	0.000439	CcSEcCtD
Temozolomide—Discomfort—Topiramate—obesity	0.000175	0.000436	CcSEcCtD
Temozolomide—Dry mouth—Topiramate—obesity	0.000173	0.000432	CcSEcCtD
Temozolomide—Confusional state—Topiramate—obesity	0.000171	0.000427	CcSEcCtD
Temozolomide—Oedema—Topiramate—obesity	0.00017	0.000423	CcSEcCtD
Temozolomide—Vomiting—Bupropion—obesity	0.000169	0.000423	CcSEcCtD
Temozolomide—Infection—Topiramate—obesity	0.000169	0.000421	CcSEcCtD
Temozolomide—Rash—Bupropion—obesity	0.000168	0.000419	CcSEcCtD
Temozolomide—Dermatitis—Bupropion—obesity	0.000168	0.000419	CcSEcCtD
Temozolomide—Headache—Bupropion—obesity	0.000167	0.000416	CcSEcCtD
Temozolomide—Nervous system disorder—Topiramate—obesity	0.000166	0.000415	CcSEcCtD
Temozolomide—Thrombocytopenia—Topiramate—obesity	0.000166	0.000415	CcSEcCtD
Temozolomide—Skin disorder—Topiramate—obesity	0.000165	0.000411	CcSEcCtD
Temozolomide—Hyperhidrosis—Topiramate—obesity	0.000164	0.000409	CcSEcCtD
Temozolomide—Anorexia—Topiramate—obesity	0.000162	0.000404	CcSEcCtD
Temozolomide—CYP3A4—Estrogen metabolism—STS—obesity	0.00016	0.0279	CbGpPWpGaD
Temozolomide—Nausea—Bupropion—obesity	0.000158	0.000395	CcSEcCtD
Temozolomide—CYP3A4—Benzo(a)pyrene metabolism—AKR1C3—obesity	0.000157	0.0275	CbGpPWpGaD
Temozolomide—Musculoskeletal discomfort—Topiramate—obesity	0.000155	0.000386	CcSEcCtD
Temozolomide—CYP3A4—Fatty Acid Omega Oxidation—ADH1B—obesity	0.000154	0.0269	CbGpPWpGaD
Temozolomide—Insomnia—Topiramate—obesity	0.000154	0.000383	CcSEcCtD
Temozolomide—Paraesthesia—Topiramate—obesity	0.000152	0.00038	CcSEcCtD
Temozolomide—Dyspnoea—Topiramate—obesity	0.000151	0.000378	CcSEcCtD
Temozolomide—Somnolence—Topiramate—obesity	0.000151	0.000376	CcSEcCtD
Temozolomide—Dyspepsia—Topiramate—obesity	0.000149	0.000373	CcSEcCtD
Temozolomide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I3—obesity	0.000149	0.0261	CbGpPWpGaD
Temozolomide—Decreased appetite—Topiramate—obesity	0.000148	0.000368	CcSEcCtD
Temozolomide—Gastrointestinal disorder—Topiramate—obesity	0.000147	0.000366	CcSEcCtD
Temozolomide—Fatigue—Topiramate—obesity	0.000146	0.000365	CcSEcCtD
Temozolomide—Constipation—Topiramate—obesity	0.000145	0.000362	CcSEcCtD
Temozolomide—Pain—Topiramate—obesity	0.000145	0.000362	CcSEcCtD
Temozolomide—Feeling abnormal—Topiramate—obesity	0.00014	0.000349	CcSEcCtD
Temozolomide—Gastrointestinal pain—Topiramate—obesity	0.000139	0.000346	CcSEcCtD
Temozolomide—CYP3A4—Liver X Receptor Pathway—SREBF1—obesity	0.000138	0.0241	CbGpPWpGaD
Temozolomide—CYP3A4—Farnesoid X Receptor  Pathway—NR0B2—obesity	0.000136	0.0238	CbGpPWpGaD
Temozolomide—CYP3A4—Drug Induction of Bile Acid Pathway—NR1I2—obesity	0.000136	0.0238	CbGpPWpGaD
Temozolomide—Urticaria—Topiramate—obesity	0.000135	0.000336	CcSEcCtD
Temozolomide—Abdominal pain—Topiramate—obesity	0.000134	0.000335	CcSEcCtD
Temozolomide—Body temperature increased—Topiramate—obesity	0.000134	0.000335	CcSEcCtD
Temozolomide—CYP3A4—Liver X Receptor Pathway—FASN—obesity	0.000131	0.023	CbGpPWpGaD
Temozolomide—Hypersensitivity—Topiramate—obesity	0.000125	0.000312	CcSEcCtD
Temozolomide—Asthenia—Topiramate—obesity	0.000122	0.000304	CcSEcCtD
Temozolomide—Pruritus—Topiramate—obesity	0.00012	0.0003	CcSEcCtD
Temozolomide—Diarrhoea—Topiramate—obesity	0.000116	0.00029	CcSEcCtD
Temozolomide—CYP3A4—Drug Induction of Bile Acid Pathway—SULT2A1—obesity	0.000113	0.0197	CbGpPWpGaD
Temozolomide—Dizziness—Topiramate—obesity	0.000112	0.00028	CcSEcCtD
Temozolomide—Vomiting—Topiramate—obesity	0.000108	0.000269	CcSEcCtD
Temozolomide—Rash—Topiramate—obesity	0.000107	0.000267	CcSEcCtD
Temozolomide—Dermatitis—Topiramate—obesity	0.000107	0.000267	CcSEcCtD
Temozolomide—Headache—Topiramate—obesity	0.000106	0.000265	CcSEcCtD
Temozolomide—CYP3A4—Farnesoid X Receptor  Pathway—SULT2A1—obesity	0.000103	0.0181	CbGpPWpGaD
Temozolomide—Nausea—Topiramate—obesity	0.000101	0.000252	CcSEcCtD
Temozolomide—CYP3A4—Irinotecan Pathway—BCHE—obesity	9.99e-05	0.0175	CbGpPWpGaD
Temozolomide—CYP3A4—Tamoxifen metabolism—SULT2A1—obesity	9.53e-05	0.0167	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARD—obesity	9.39e-05	0.0164	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—NR1I3—obesity	8.98e-05	0.0157	CbGpPWpGaD
Temozolomide—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—obesity	8.67e-05	0.0152	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I3—obesity	8.56e-05	0.015	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—NR1I2—obesity	7.83e-05	0.0137	CbGpPWpGaD
Temozolomide—CYP3A4—Estrogen metabolism—NQO1—obesity	7.8e-05	0.0136	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYB5A—obesity	7.61e-05	0.0133	CbGpPWpGaD
Temozolomide—CYP3A4—Xenobiotics—CYP2E1—obesity	7.25e-05	0.0127	CbGpPWpGaD
Temozolomide—CYP3A4—Tamoxifen metabolism—CYP2E1—obesity	6.97e-05	0.0122	CbGpPWpGaD
Temozolomide—CYP3A4—Aflatoxin activation and detoxification—GGT1—obesity	6.93e-05	0.0121	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—SULT2A1—obesity	6.81e-05	0.0119	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—ECHS1—obesity	6.72e-05	0.0118	CbGpPWpGaD
Temozolomide—CYP3A4—Estrogen metabolism—COMT—obesity	6.53e-05	0.0114	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—HADH—obesity	6.32e-05	0.011	CbGpPWpGaD
Temozolomide—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—obesity	6.17e-05	0.0108	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP26B1—obesity	6.09e-05	0.0107	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP26B1—obesity	6.01e-05	0.0105	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP26B1—obesity	4.94e-05	0.00864	CbGpPWpGaD
Temozolomide—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—obesity	4.81e-05	0.00842	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—obesity	4.74e-05	0.00829	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA1—obesity	4.5e-05	0.00787	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—ADH1B—obesity	4.33e-05	0.00758	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—obesity	4.07e-05	0.00711	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CYP2E1—obesity	3.72e-05	0.00651	CbGpPWpGaD
Temozolomide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—obesity	3.68e-05	0.00643	CbGpPWpGaD
Temozolomide—CYP3A4—Tryptophan metabolism—CYP19A1—obesity	3.32e-05	0.0058	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—obesity	3.12e-05	0.00545	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—obesity	3.01e-05	0.00527	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—obesity	2.97e-05	0.0052	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—NCOA1—obesity	2.72e-05	0.00476	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—obesity	2.68e-05	0.00469	CbGpPWpGaD
Temozolomide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—obesity	2.65e-05	0.00463	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP26B1—obesity	2.62e-05	0.00459	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP26B1—obesity	2.59e-05	0.00453	CbGpPWpGaD
Temozolomide—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—obesity	2.58e-05	0.0045	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—obesity	2.44e-05	0.00427	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—ADH1B—obesity	2.3e-05	0.00403	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—NCOA1—obesity	2.21e-05	0.00386	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—obesity	2.17e-05	0.0038	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—SULT2A1—obesity	1.77e-05	0.0031	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—SULT2A1—obesity	1.75e-05	0.00306	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—GPX3—obesity	1.67e-05	0.00292	CbGpPWpGaD
Temozolomide—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—obesity	1.61e-05	0.00282	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—AKR1C3—obesity	1.46e-05	0.00256	CbGpPWpGaD
Temozolomide—CYP3A4—Phase 1 - Functionalization of compounds—POMC—obesity	1.31e-05	0.00229	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP2E1—obesity	1.3e-05	0.00227	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP2E1—obesity	1.28e-05	0.00224	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—GGT1—obesity	1.19e-05	0.00208	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—NCOA1—obesity	1.17e-05	0.00205	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—CYP19A1—obesity	1.16e-05	0.00202	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—CYP19A1—obesity	1.14e-05	0.00199	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CA3—obesity	1.08e-05	0.00189	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—COMT—obesity	1.07e-05	0.00188	CbGpPWpGaD
Temozolomide—CYP3A4—Metapathway biotransformation—COMT—obesity	1.06e-05	0.00185	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GLRX—obesity	9.19e-06	0.00161	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—INSIG2—obesity	8.19e-06	0.00143	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ETFDH—obesity	8.19e-06	0.00143	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPM1L—obesity	8.19e-06	0.00143	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—OTC—obesity	8.19e-06	0.00143	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—INPP5E—obesity	7.49e-06	0.00131	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—UQCRC2—obesity	7.49e-06	0.00131	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GPT—obesity	7.49e-06	0.00131	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALDH6A1—obesity	6.96e-06	0.00122	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ME1—obesity	6.96e-06	0.00122	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SUCLG2—obesity	6.96e-06	0.00122	CbGpPWpGaD
Temozolomide—CYP3A4—Biological oxidations—POMC—obesity	6.94e-06	0.00121	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—COX7C—obesity	6.55e-06	0.00115	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PNPLA3—obesity	6.55e-06	0.00115	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—UCP1—obesity	6.55e-06	0.00115	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CS—obesity	6.21e-06	0.00109	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—DGAT2—obesity	6.21e-06	0.00109	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SUCLA2—obesity	6.21e-06	0.00109	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CPS1—obesity	6.21e-06	0.00109	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—MUT—obesity	5.92e-06	0.00104	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LIPE—obesity	5.92e-06	0.00104	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—DGAT1—obesity	5.68e-06	0.000993	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYB5A—obesity	5.68e-06	0.000993	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ACLY—obesity	5.47e-06	0.000956	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALOX12—obesity	5.28e-06	0.000923	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ENPP1—obesity	5.28e-06	0.000923	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HMGCS1—obesity	5.11e-06	0.000894	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PNPLA2—obesity	4.96e-06	0.000868	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PFKFB3—obesity	4.96e-06	0.000868	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ANGPTL4—obesity	4.96e-06	0.000868	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ACADM—obesity	4.96e-06	0.000868	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PLIN1—obesity	4.96e-06	0.000868	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SAT1—obesity	4.96e-06	0.000868	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ACACB—obesity	4.83e-06	0.000844	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYTB—obesity	4.83e-06	0.000844	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—OXCT1—obesity	4.83e-06	0.000844	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PNLIP—obesity	4.7e-06	0.000823	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SRD5A1—obesity	4.7e-06	0.000823	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SDC3—obesity	4.59e-06	0.000803	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HK2—obesity	4.49e-06	0.000785	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—STS—obesity	4.49e-06	0.000785	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP26B1—obesity	4.49e-06	0.000785	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARD—obesity	4.39e-06	0.000768	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SLC27A1—obesity	4.3e-06	0.000753	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—FABP4—obesity	4.22e-06	0.000738	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GLUL—obesity	4.22e-06	0.000738	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ECHS1—obesity	4e-06	0.0007	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—UCP2—obesity	4e-06	0.0007	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HSD11B1—obesity	4e-06	0.0007	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—UCP3—obesity	4e-06	0.0007	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ADH1B—obesity	3.94e-06	0.000688	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ACSL1—obesity	3.87e-06	0.000678	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GPAM—obesity	3.87e-06	0.000678	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARGC1B—obesity	3.87e-06	0.000678	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HADH—obesity	3.76e-06	0.000658	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—FADS1—obesity	3.76e-06	0.000658	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PCK1—obesity	3.76e-06	0.000658	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ACP5—obesity	3.66e-06	0.00064	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—G6PD—obesity	3.57e-06	0.000624	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SREBF2—obesity	3.52e-06	0.000616	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HK1—obesity	3.52e-06	0.000616	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LPA—obesity	3.4e-06	0.000595	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LPIN1—obesity	3.33e-06	0.000582	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOA5—obesity	3.26e-06	0.00057	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CLOCK—obesity	3.11e-06	0.000544	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SLC22A1—obesity	3.11e-06	0.000544	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GLP1R—obesity	3.03e-06	0.00053	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SULT2A1—obesity	3.03e-06	0.00053	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—DPYD—obesity	2.98e-06	0.000522	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PRKAR2B—obesity	2.87e-06	0.000502	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—DCN—obesity	2.85e-06	0.000499	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CPT1A—obesity	2.77e-06	0.000485	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—NAMPT—obesity	2.72e-06	0.000476	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LIPC—obesity	2.7e-06	0.000473	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GCK—obesity	2.7e-06	0.000473	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOC3—obesity	2.69e-06	0.00047	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CETP—obesity	2.61e-06	0.000456	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SDC1—obesity	2.58e-06	0.000451	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—AKR1C3—obesity	2.54e-06	0.000444	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SCARB1—obesity	2.5e-06	0.000437	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SREBF1—obesity	2.42e-06	0.000424	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GOT2—obesity	2.36e-06	0.000412	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—FASN—obesity	2.31e-06	0.000404	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—BCHE—obesity	2.3e-06	0.000402	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP2E1—obesity	2.22e-06	0.000388	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—NQO1—obesity	2.19e-06	0.000383	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GCG—obesity	2.1e-06	0.000368	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—SLC2A4—obesity	2.1e-06	0.000368	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYCS—obesity	2.07e-06	0.000363	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GOT1—obesity	2.04e-06	0.000356	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GGT1—obesity	2.04e-06	0.000356	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—NCOA1—obesity	2e-06	0.000351	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—STK11—obesity	1.98e-06	0.000346	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CYP19A1—obesity	1.98e-06	0.000346	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—COMT—obesity	1.84e-06	0.000321	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARGC1A—obesity	1.81e-06	0.000317	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GNB3—obesity	1.81e-06	0.000317	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—HMOX1—obesity	1.8e-06	0.000315	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GNAS—obesity	1.76e-06	0.000308	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOB—obesity	1.73e-06	0.000302	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—LPL—obesity	1.65e-06	0.000288	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—GPX1—obesity	1.61e-06	0.000281	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CD36—obesity	1.57e-06	0.000274	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—MTHFR—obesity	1.48e-06	0.00026	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARA—obesity	1.46e-06	0.000255	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—AGT—obesity	1.41e-06	0.000247	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOE—obesity	1.38e-06	0.000242	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—CAV1—obesity	1.37e-06	0.00024	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—APOA1—obesity	1.37e-06	0.000239	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PIK3CG—obesity	1.25e-06	0.000218	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PPARG—obesity	1.2e-06	0.000211	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—POMC—obesity	1.19e-06	0.000208	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—INS—obesity	1.18e-06	0.000207	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PIK3CD—obesity	1.1e-06	0.000192	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—ALB—obesity	1.08e-06	0.000189	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—NOS3—obesity	1.04e-06	0.000181	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PIK3R1—obesity	1.04e-06	0.000181	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PIK3CB—obesity	9.56e-07	0.000167	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PTGS2—obesity	9.47e-07	0.000166	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—PIK3CA—obesity	5.83e-07	0.000102	CbGpPWpGaD
Temozolomide—CYP3A4—Metabolism—AKT1—obesity	4.76e-07	8.33e-05	CbGpPWpGaD
